(January 6, 2025) – As part of their strategic plan, ONE MUSC, the Medical University of South Carolina has developed an aspirational goal of becoming a top 20 academic health system in the nation leading South Carolina into the top 20 in the
nation for health outcomes.
To help meet this goal, MUSC is driving innovation and health transformation to accelerate preeminence in five key areas of strength (cancer, digestive health, heart and vascular, neurosciences, and precision health). GGC’s President and CEO, Steve Skinner, MD, has been tapped to be the clinical lead on efforts in the area of precision health.
Skinner noted that these precision health efforts will require significant cross-institutional support and common infrastructure in areas such as clinical trials, big data/AI, and genomics. He will also serve as Chair of MUSC’s
Integrated Center of Clinical Excellence (ICCE) in Genetics and Genomics. MUSC has 17 ICCE care models designed to improve the patient experience and achieve optimal patient outcomes.
“These new leadership roles are a significant step forward in our fruitful partnership with MUSC and will create more opportunities for GGC to be a model and vehicle for precision health,” said Skinner. “This opportunity will also enhance the success and sustainability of GGC’s internal precision medicine initiative, and expand our impact on patient care across South Carolina,” said Skinner.
Skinner will be phasing in these new responsibilities over the coming months and will continue to lead GGC with a focus on strategic priorities and state agency and legislative relationships. To delegate other day-to-day operational responsibilities, GGC has created a new position, Chief Administration Officer, and Mike Lyons, MD, Curry Chair in Translational Genomics and Therapeutics, will oversee the Center’s scientific and educational divisions as Chief Genomics Officer.